Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 946-072-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Genetic toxicity in vitro:
To address the endpoint genetic toxicity, read-across on gluconates and derivatives and iron compounds was performed within the frame of a weight of evidence approach. The underlying hypothesis for the read-across is that glucoheptonates and gluconates, structurally similar sugar-like carbohydrate metal-complexes, share the same metabolism pathways in mammals (they are oxidized by pentose phosphate pathway) and that their possible toxicity is a function of the metal cation rather than of the gluconate or glucoheptonate anion.
The overall conclusion on mutagenicity of iron glucoheptonate is based on several studies available for gluconates, its derivatives, and iron compounds. The registered substance is not considered to be genotoxic because all available genetic toxicity studies in vitro in bacterial cells and yeasts conducted with sodium ferric gluconate complex in sucrose injection, iron dichloride and sodium gluconate or glucono-delta-lactone were negative. The positive outcomes of the in vitro studies with sodium ferric gluconate complex in sucrose (Ferrlecit) and other iron compounds on mammalian cells are indicative of the potentiated formation of active oxygen species under overload condition. They are not indicative for a primary mutagenic effect and are not relevant to the genetic toxicity of the registered substance.
Data on sodium ferric gluconate complex in sucrose injection
Gene Mutation was evaluated in an Ames Test. The employed doses were 0.625 - 5.00 mg Fe/plate. The number of revertants per plate was counted. No positive increase in the number of revertants per plate of any of the tester strains with / without microsomal enzymes prepared from AroclorTM -induced rat liver (S9). The results of the tests show that Ferrlecit is negative for genetic mutagenicity sanofi-aventis, 2009).
Clastogenicity was evaluated in chinese hamster ovary cells. The employed doses were 225 - 1250 µg Fe/mL. The number of cells with chromosomal aberrations was counted.
No significant increase in cells with chromosomal aberrations was observed in the cultures analyzed from the non-activation assay. In the assay with metabolic activation, however, significant increases in cells with chromosomal aberrations were observed at the 10-hour harvest in the cultures dosed with 1250 μg Fe/mL Ferrlecit® and at all dose levels (313 to 1250 μg Fe/mL Ferrlecit®) at the 20-hour harvest. The response was highly variable between replicate cultures and was not dose-related. These results were indicative of ferric ion potentiated formation of active oxygen species by the S9 system rather than any metabolic activation of the test article. Such a "test system-generated" response would make the utilization of S9 inappropriate for screening this test article for clastogenic activity. Taking this explanation into account, the results of the tests show that Ferrlecit is negative for genetic mutagenicity (sanofi-aventis, 2009).
These results are of high relevance for the substance iron glucoheptonate, since sodium ferric gluconate complex in sucrose injection is a highly recommended read across substance, due to its similar chemical behaviour and its similar uses.
Data on iron dichloride
A bacterial reverse mutation test, according to OECD test guideline 471 with iron dichloride was performed in compliance with GLP. It was concluded that iron dichloride did not exhibit mutagenic activity to any test strains under the test conditions (SIDS 2004).
Data on iron gluconate
The mutagenicity iron gluconate was examined in Ames' tester strains, Salmonella typhimurium TA97 and TA102. The mutation test was carried out by the preincubation procedure described by Ames et al. The test chemicals were preincubated with S9 mix or phosphate buffer (pH7.4) for 20 min. Iron gluconate was negative in two tester strains (Fujita et al. 1994).
Brusick (1975) also evaluated iron gluconate (Compound 000299296) for genetic activity in a series of in vitro microbial assays with and without metabolic activation. In Salmonella typhimurium plate tests, ferrous gluconate was not mutagenic for the bacterial indicator organisms used in the direct and activation plate tests at a concentration of 0.079 %. In nonactivation suspension tests, the results were negative. However, in activation suspension tests, the compound was positive in activation tests with TA-1538 and primate liver tissue.
In nonactivation and activation tests with Saccharomyces cerevisiae, the results were negative (Brusick, 1975). In cotrast, iron gluconate, appeared to be mutagenic for indicator strain TA-1538 in activation tests with primate liver activation homogenate.
However, the overall result of iron gluconate is negative. This is based on the following arguments.
a) the "traditional" S- Typhimurium strains 1535 and 1537 were always negative
b) the "unusual" S. typhimurium strain 1538 was negative in tests with the "traditional" rats S9 metabolic activation system.
c) nonactivation and activation tests with saccharomyces cerevisiae were negative.
Therefore the single - even though repeatable - positive result obtained in Strain 1538 with monkey liver S9 fraction is overruled.
Data on several iron compounds and elemental iron
The mutagenic activity of elemental and salt forms of iron (Fe), including compounds were evaluated for mutagenicity in L5178Y mouse lymphoma cells (Dunkel et al. 1999).
Ferric chloride (FeCl3) and ferric phosphate (FePO4), induced an increase in mutant frequency only with S9. With ferrous sulfate (FeSO4) and ferrous fumarate (FeC4H2O4), on the other hand, positive responses were observed without S9. The Fe chelate, sodium Fe(III)EDTA was positive in both the presence and absence of S9.
These divergent responses were related to the different oxidation states of iron in the different compounds. The oxidation state of iron is also influenced by liver S9 mix. NADP and reductase in the liver S9 mix lead to the reduction of ferric (Fe3+) to ferrous (Fe2+). The transferrin-independent transport system requires the reduced form of iron (Fe2 +). Thus, Fe2+ is absorbed by the cells more effectively, which is accompanied by an increased toxicity of Fe2 + when compared to Fe3 +.
The positive genotoxic response of mouse lymphoma cells to Fe2+ is most likely to be caused by the activation of the oxygen species H2O2 and superoxide (O2 -*), which may result in the formation of the hydroxyl radical (*OH), the most powerful DNA-damaging radical. Attack of *OH on DNA produces a variety of different products and all purine and pyrimidine bases can be modified (Dunkel et al. 1999).
Data on gluconates and derivatives
Sodium gluconate, glucono-delta-lactone and calcium gluconate were tested on Saccharomyces cerevisiae and Salmonella typhimurium with and without metabolic activation similar to OECD Guideline 471. The substances were tested on Saccharomyces cerevisiae (strain D4) and Salmonella typhimurium (3 strains) with and without metabolic activation. Only 3 concentrations were tested where OECD guideline recommends at least 5 concentrations. None of the test substances showed mutagenicity on the strains tested.
The genetic toxicity of monosaccharides, disaccharides, and related ingredients as used in cosmetics was determined. The genotoxicity of a number of the mono- and disaccharides has been evaluated in in vitro and in vivo studies and the results of these studies are negative.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Iron gluconate and iron glucoheptonate are structurally similar sugar-like substances with the same functional groups, whereby gluconate and glucoheptonate anions share similar chemical moiety. They differ only in one carbon segment (HCOH): glucoheptonate is longer (C7) than gluconate (C6). Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate, releasing their metals that can further interact with a variety of cellular proteins, while no genetic toxicity potential can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, leading to adverse mutagenicity and/or clastogenicity effects.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Source Chemical: sodium ferric gluconate complex in sucrose injection
The substances do not contain impurities to an extent which is expected to alter the outcome of the experimental results or read-across approach.
Target Chemical: Sodium Iron glucoheptonate complex (HGA:Fe-1:1), CAS 1821694-04-5,
SMILES [Na+].[H]C([H])(O)C([H])(O)C1([H])O[Fe]2OC([H])(C([O-])=O)C([H])(O2)C1([H])O,
MW 354.8 g/mol (trihydrated from) or 300.8g/mol (anhydrous form)
The molecular formula is C7FeH10NaO8 *3H2O (trihydrated form).
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The calculation of a hazard value for iron glucoheptonate is based on 76 % content of iron glucoheptonate in the registered product. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Ammonium sulfate was not mutagenic in bacteria (Ames test) and yeasts with and without metabolic activation systems. It did not induce chromosomal aberrations in mammalian or human cell cultures. Therefore, the iron ion is the only toxicological relevant component of the registered substance.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconate and glucoheptonate anions share similar chemical moiety. Iron is also the same cation in both chemicals. They dissociate according the same scheme: 1:1 iron and gluconate or glucoheptonate are released. Therefore, genetic toxicity of both chemicals is expected to be very similar.
4. DATA MATRIX
data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- other: all strains tested
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Conclusions:
- These results are of high relevance for the substance iron glucoheptonate, since sodium ferric gluconate complex in sucrose injection is a highly recommended read across substance, due to its similar chemical behaviour and its similar uses.
- Executive summary:
Gene Mutation was evaluated in an Ames Test (sanofi-aventis Canada Inc., 2009). The employed doses were 0.625 - 5.00 mg Fe/plate. The number of revertants per plate was counted. No positive increase in the number of revertants per plate of any of the tester strains with / without microsomal enzymes prepared from AroclorTM -induced rat liver (S9). The results of the tests show that Ferrlecit is negative for genetic mutagenicity.
These results are of high relevance for the substance iron glucoheptonate, since sodium ferric gluconate complex in sucrose injection is a highly recommended read across substance, due to its similar chemical behaviour and its similar uses.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Iron gluconate and iron glucoheptonate are structurally similar sugar-like substances with the same functional groups, whereby gluconate and glucoheptonate anions share similar chemical moiety. They differ only in one carbon segment (HCOH): glucoheptonate is longer (C7) than gluconate (C6). Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate, releasing their metals that can further interact with a variety of cellular proteins, while no genetic toxicity potential can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, leading to adverse mutagenicity and/or clastogenicity effects.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Source Chemical: sodium ferric gluconate complex in sucrose injection
The substances do not contain impurities to an extent which is expected to alter the outcome of the experimental results or read-across approach.
Target Chemical: Sodium Iron glucoheptonate complex (HGA:Fe-1:1), CAS 1821694-04-5,
SMILES [Na+].[H]C([H])(O)C([H])(O)C1([H])O[Fe]2OC([H])(C([O-])=O)C([H])(O2)C1([H])O,
MW 354.8 g/mol (trihydrated from) or 300.8g/mol (anhydrous form)
The molecular formula is C7FeH10NaO8 *3H2O (trihydrated form).
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The calculation of a hazard value for iron glucoheptonate is based on 76 % content of iron glucoheptonate in the registered product. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Ammonium sulfate was not mutagenic in bacteria (Ames test) and yeasts with and without metabolic activation systems. It did not induce chromosomal aberrations in mammalian or human cell cultures. Therefore, the iron ion is the only toxicological relevant component of the registered substance.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconate and glucoheptonate anions share similar chemical moiety. Iron is also the same cation in both chemicals. They dissociate according the same scheme: 1:1 iron and gluconate or glucoheptonate are released. Therefore, genetic toxicity of both chemicals is expected to be very similar.
4. DATA MATRIX
data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- other: all strains tested
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Conclusions:
- The results of the tests are considered to show that Ferrlecit is negative for genetic mutagenocity.
These results are of high relevance for the substance iron glucoheptonate, since sodium ferric gluconate complex in sucrose injection is a highly recommended read across substance, due to its similar chemical behaviour and its similar uses. - Executive summary:
Clastogenicity was evaluated in chinese hamster ovary cells. The employed doses were 225 - 1250 µg Fe/mL. The number of cells with chromosomal aberrations was counted.
No significant increase in cells with chromosomal aberrations was observed in the cultures analyzed from the non-activation assay. In the assay with metabolic activation, however, significant increases in cells with chromosomal aberrations were observed at the 10-hour harvest in the cultures dosed with 1250 μg Fe/mL Ferrlecit® and at all dose levels (313 to 1250 μg Fe/mL Ferrlecit®) at the 20-hour harvest. The response was highly variable between replicate cultures and was not dose-related. These results were indicative of ferric ion potentiated formation of active oxygen species by the S9 system rather than any metabolic activation of the test article. Such a "test system-generated" response would make the utilization of S9 inappropriate for screening this test article for clastogenic activity. Taking this explanation into account, the results of the tests show that Ferrlecit is negative for genetic mutagenicity.
These results are of high relevance for the substance iron glucoheptonate, since sodium ferric gluconate complex in sucrose injection is a highly recommended read across substance, due to its similar chemical behaviour and its similar uses.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Iron gluconate and iron glucoheptonate are structurally similar sugar-like substances with the same functional groups, whereby gluconate and glucoheptonate anions share similar chemical moiety. They differ only in one carbon segment (HCOH): glucoheptonate is longer (C7) than gluconate (C6). Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate, releasing their metals that can further interact with a variety of cellular proteins, while no genetic toxicity potential can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, leading to adverse mutagenicity and/or clastogenicity effects.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Ammonium sulfate was not mutagenic in bacteria (Ames test) and yeasts with and without metabolic activation systems. It did not induce chromosomal aberrations in mammalian or human cell cultures. Therefore, the iron ion is the only toxicological relevant component of the registered substance.
There is limited information on purity of iron gluconate in this study. Purity of 100 % was therefore assumed.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconate and glucoheptonate anions share similar chemical moiety. Iron is also the same cation in both chemicals. They dissociate according the same scheme: 1:1 iron and gluconate or glucoheptonate are released. Therefore, genetic toxicity of both chemicals is expected to be very similar.
4. DATA MATRIX
data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- not specified
- Remarks on result:
- other:
- Remarks:
- with liver homogenate, lung homogentate or testes homogenate from mouse, rat or monkey
- Conclusions:
- The overall result of Ferrous gluconate is negative. This is based on the following arguments.
a) the "traditional" S- Typhimurium strains 1535 and 1537 were always negative
b) the "unusual" S. typhimurium strain 1538 was negative in tests with the "traditional" rats S9 metabolic activation system.
Therefore the single - even though repeatable - positive result obtained in Strain 1538 with monkey liver S9 fraction is overruled.
This result is also relevant for iron glucoheptonate, as ferrous gluconate is highly similar to iron glucoheptonate,, which is therefore considered to be also "not mutagenic" according to 1272/2008/EC. - Executive summary:
Compound 000299296, Ferrous Gluconate, was evaluated for genetic activity in a series of in vitro microbial assays with and without metabolic activation (Brusick, 1975). In Salmonella typhimurium plate tests, 000299296 was not mutagenic for the bacterial indicator organisms used in the direct and activation plate tests at a concentration of 0.079 %. In nonactivation suspension tests, the results were negative. However, in activation suspension tests, the compound was positive in activation tests with TA-1538 and primate liver tissue. The tests were repeated and the results appeared positive. No other tests were positive with this compound.
In nonactivation and activation tests with saccharomyces cerevisiae, the results were negative.
Though, compound 000299296, Ferrous Gluconate, appeared to be mutagenic for indicator strain TA-1538 in activation tests with primate liver activation homogenate.
However, the overall result of Ferrous gluconate is negative. This is based on the following arguments.
a) the "traditional" S- Typhimurium strains 1535 and 1537 were always negative
b) the "unusual" S. typhimurium strain 1538 was negative in tests with the "traditional" rats S9 metabolic activation system.
c) nonactivation and activation tests with saccharomyces cerevisiae were negative.
Therefore the single - even though repeatable - positive result obtained in Strain 1538 with monkey liver S9 fraction is overruled.
These results are also relevant for iron glucoheptonate, as ferrous gluconate is highly similar to iron glucoheptonate, which is therefore considered to be also not mutagenic.
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: other: summary of available in vitro and in vivo genetic toxicity data
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate on releasing their metals that can further interact with a variety of cellular proteins, while no genetic toxicity potential can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, leading to adverse mutagenicity and/or clastogenicity effects. So, information on genetic toxicity of gluconate anion allows to strengthen the read-across approach, excluding genetic toxicity potential of the organic part of the molecule.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Ammonium sulfate was not mutagenic in bacteria (Ames test) and yeasts with and without metabolic activation systems. It did not induce chromosomal aberrations in mammalian or human cell cultures. Therefore, the iron ion is the only toxicological relevant component of the registered substance.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconates are not mutagenic in bacterial strains. Due to high structural similarity and the fact that gluconates and glucoheptonates are carbohydrates used by cells in high amounts, no mutagenicity is expected for glucoheptonate anion.
4. DATA MATRIX
please refer to the detailled data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- S. typhimurium, other: TA 1535; TA 1537 and TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- The available in vitro mutagenicity data with glucono-delta-lactone, sodium or calcium gluconate were negative.
These results are also relevant for iron glucoheptonate, as the glucoheptonate-residue is also a derivative of gluconic acid. Therefore, the fact that these gluconates are not mutagenic is important. - Executive summary:
Sodium gluconate, glucono-delta-lactone and calcium gluconate were tested on Saccharomyces cerevisiae and Salmonella typhimurium with and without metabolic activation. OECD Guideline 471 was deviated for the number of strains tested and the choice of positive controls. The substances were tested on Saccharomyces cerevisiae (strain D4) and Salmonella typhimurium (3 strains) with and without metabolic activation. Only 3 concentrations were tested where OECD guideline recommends at least 5 concentrations. None of the test substances showed mutagenicity on the strains tested.
These results are also relevant for iron glucoheptonate, as the glucoheptonate-residue is also a derivative of gluconic acid. Therefore, the fact that these gluconates are not mutagenic is important.
- Endpoint:
- genetic toxicity in vitro
- Remarks:
- Type of genotoxicity: other: summary of mutagenicity data
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate on releasing their metals that can further interact with a variety of cellular proteins, while no genetic toxicity potential can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, leading to adverse mutagenicity and/or clastogenicity effects. So, information on genetic toxicity of gluconate anion allows to strengthen the read-across approach, excluding genetic toxicity potential of the organic part of the molecule.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Ammonium sulfate was not mutagenic in bacteria (Ames test) and yeasts with and without metabolic activation systems. It did not induce chromosomal aberrations in mammalian or human cell cultures. Therefore, the iron ion is the only toxicological relevant component of the registered substance.
Gluconates used in genetic toxicity studies described in this record do not include impurities that are different from those contained in the target substance and which would influence genetic toxicity potential. Moreover, since the data originate from a review, no detailed information on purity and impurities could be extracted. However, the results on mutagenicity of gluconates summarised in this Cosmetic ingredient review are peer-reviewed and therefore any impurity that would influence mutagenicity result of the tested substances is assessed by the Panel and therefore could be excluded as not relevant for the present assessment.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconates are not mutagenic in bacterial strains. Due to high structural similarity and the fact that gluconates and glucoheptonates are carbohydrates used by cells in high amounts, no mutagenicity is expected for glucoheptonate anion.
4. DATA MATRIX
data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- other: The genotoxicity of a number of the mono- and disaccharides has been evaluated in in vitro and in vivo studies. The results of these studies are overwhelmingly negative.
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Vehicle controls validity:
- other: not applicable (summary result)
- Untreated negative controls validity:
- other: not applicable (summary result)
- Positive controls validity:
- other: not applicable (summary result)
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- The genotoxicity of a number of the mono- and disaccharides has been evaluated in in vitro and in vivo studies. The results of these studies are overwhelmingly negative.
These results are also relevant for iron glucoheptonate, as the glucoheptonate-residue is also a derivative of gluconic acid. Therefore, the fact that these mono- and disaccharides are not mutagenic is important. - Executive summary:
Summary of genetic toxicity study results conducted with monosaccharides, disaccharides, and related ingredients as used in cosmetics.
The genotoxicity of a number of the mono- and disaccharides has been evaluated in in vitro and in vivo studies. The results of these studies are overwhelmingly negative.
These results are also relevant for iron glucoheptonate, as the glucoheptonate-residue is also a derivative of gluconic acid. Therefore, the fact that these mono- and disaccharides are not mutagenic is important.
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Iron gluconate and iron glucoheptonate are structurally similar sugar-like substances with the same functional groups, whereby gluconate and glucoheptonate anions share similar chemical moiety. They differ only in one carbon segment (HCOH): glucoheptonate is longer (C7) than gluconate (C6). Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate, releasing their metals that can further interact with a variety of cellular proteins, while no genetic toxicity potential can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, leading to adverse mutagenicity and/or clastogenicity effects.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Ammonium sulfate was not mutagenic in bacteria (Ames test) and yeasts with and without metabolic activation systems. It did not induce chromosomal aberrations in mammalian or human cell cultures. Therefore, the iron ion is the only toxicological relevant component of the registered substance.
There is limited information on purity of iron gluconate in this study. Purity of 100 % was therefore assumed.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconate and glucoheptonate anions share similar chemical moiety. Iron is also the same cation in both chemicals. They dissociate according the same scheme: 1:1 iron and gluconate or glucoheptonate are released. Therefore, genetic toxicity of both chemicals is expected to be very similar.
4. DATA MATRIX
data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- S. typhimurium TA 97
- Remarks:
- Iron gluconate
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 102
- Remarks:
- Iron gluconate
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- Iron gluconate was negative in two tester strains Salmonella typhimurium TA97 and TA102. Thus, it is very likely that iron glucoheptonate is also negative in Ames test.
- Executive summary:
The mutagenicity of 34 food additives including 10 seasonings, 6 bases for processing, 5 flavouring agents and 13 others were examined in Ames' tester strains, Salmonella typhimurium TA97 and TA102. The mutation test was carried out by the preincubation procedure described by Ames et al. The test chemicals were preincubated with S9 mix or phosphate buffer (pH7.4) for 20 min. Iron gluconate was negative in two tester strains.
This result is also relevant for iron glucoheptonate, as ferrous gluconate is highly similar to iron glucoheptonate, which is therefore considered to be also negative in Ames test.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate in organic fluids releasing their metals that can further interact with a variety of biomolecules, while no genetic toxicity can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, producing an adverse genotoxicity effect. Therefore, data on genetic toxicity potential of several organic and inorganic iron compounds have been taken into account to address genetic toxicity potential of iron cation which could be released from the iron glucoheptonate.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Ammonium sulfate was not mutagenic in bacteria (Ames test) and yeasts with and without metabolic activation systems. It did not induce chromosomal aberrations in mammalian or human cell cultures. Therefore, the iron ion is the only toxicological relevant component of the registered substance.
The purity of the iron compounds used in this study range between 98 and 100 %.
3. ANALOGUE APPROACH JUSTIFICATION
Since glucoheptonate anion is considered not mutagenic to bacterial strains, certain mutagenicity potential, if any, could be attributed to iron. Therefore, data on mutagenicity of inorganic iron compounds are used to address mutagenicity of iron.
4. DATA MATRIX
please refer to the detailled data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- Electrolytic Fe (particle size 16 µm)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- Carbonyl Fe (particle size 3 µm)
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- FeSO4
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- ferrous fumarate
- Metabolic activation:
- without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- ferrous fumarate
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- FeCl3, FePO4
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- mouse lymphoma L5178Y cells
- Remarks:
- NaFeEDTA
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- In the mouse lymphoma assay, responses were related to the Fe compound and/or reduction of ferric (Fe3+) to ferrous (Fe2+). With ferric chloride (FeCl3) and ferric phosphate (FePO4), there was an increase in mutant frequency only with S9. With the Fe2+ compounds, ferrous sulfate (FeSO4) and ferrous fumarate (FeC4H2O4), positive responses were observed without S9. The Fe chelate, sodium Fe(III)EDTA was positive in both the presence and absence of S9. NaFe EDTA is the most relevant source substance for the chelate iron glucoheptonate.
A possible explanation for the genotoxicity is the activation of the oxygen species, H2O2 and superoxide (O2 -*) by Fe, which may result in the formation of the hydroxyl radical (*OH), the most powerful DNA-damaging radical. Attack of *OH on DNA produces a variety of different products and all purine and pyrimidine bases can be modified. - Executive summary:
In the mouse lymphoma assay, responses were related to the Fe compound and/or reduction of ferric (Fe3+) to ferrous (Fe2+). With ferric chloride (FeCl3) and ferric phosphate (FePO4), there was an increase in mutant frequency only with S9. With the Fe2+ compounds, ferrous sulfate (FeSO4) and ferrous fumarate (FeC4H2O4), positive responses were observed without S9. The Fe chelate, sodium Fe(III)EDTA was positive in both the presence and absence of S9. NaFe EDTA is the most relevant source substance for the chelate iron glucoheptonate.
A possible explanation for the genotoxicity is the activation of the oxygen species, H2O2 and superoxide (O2 -*) by Fe, which may result in the formation of the hydroxyl radical (*OH), the most powerful DNA-damaging radical. Attack of *OH on DNA produces a variety of different products and all purine and pyrimidine bases can be modified.
Referenceopen allclose all
No positive increase in the number of revertants per plate of any of the tester strains with / without microsomal enzymes prepared from AroclorTM -induced rat liver (S9).
No significant increase in cells with chromosomal aberrations was observed in the cultures analyzed from the non-activation assay. In the assay with metabolic activation, however, significant increases in cells with chromosomal aberrations were observed at the 10-hour harvest in the cultures dosed with 1250 μg Fe/mL Ferrlecit® and at all dose levels (313 to 1250 μg Fe/mL Ferrlecit®) at the 20-hour harvest. The response was highly variable between replicate cultures and was not dose-related. These results were indicative of ferric ion potentiated formation of active oxygen species by the S9 system rather than any metabolic activation of the test article. Such a "test system-generated" response would make the utilization of S9 inappropriate for screening this test article for clastogenic activity.
Compound 000299296, Ferrous Gluconate, was evaluated for genetic activity in a series of in vitro microbial assays with and without metabolic activation. The following results were obtained:
A. Salmonella typhimurium
1. Plate Tests - At a concentration of 0.079%, 000299296 was not mutagenic for the bacterial indicator organisms used in the direct and activation plate tests.
2. Nonactivation suspension tests - The results of these tests were negative.
3. Activation suspension tests - The results of these tests indicate that this compound is positive in activation tests with TA-1538 and primate liver tissue. The tests were repeated and the results appeared positive. No other tests were positive with this compound.
B. Saccharomyces cerevisiae
1. Nonactivation suspension tests - The results of these tests were negative.
2. Activation suspension tests - The results of these tests were negative.
C. Conclusions - Compound 000299296, Ferrous Gluconate, appeared to be mutagenic for indicator strain TA-1538 in activation tests with primate liver tissue. No other tests with this compound were positive.
Table 2 - Overall Summary Of Test Results |
|||||||||
Plate Tests |
|||||||||
A. |
Name or code designation of test compound: |
000299296 |
|||||||
B. |
Test date: |
02/14/75 |
|||||||
C. |
Concentration of the test compound: |
0.07% |
|||||||
Test |
Species |
Tissue |
TA-1535 |
TA-1537 |
TA-1538 |
||||
|
|
1 |
2 |
1 |
2 |
1 |
2 |
||
1. Non-activation |
|||||||||
Solvent Control |
--- |
--- |
47 |
78 |
11 |
14 |
26 |
6 |
|
Positive Controla |
--- |
--- |
>103 |
>103 |
209 |
301 |
147 |
140 |
|
Test Compound |
--- |
--- |
47 |
17 |
3 |
3 |
11 |
6 |
|
2. Activation |
|||||||||
Negative Control |
--- |
--- |
40 |
90 |
14 |
22 |
14 |
4 |
|
Solvent Control |
--- |
--- |
27 |
89 |
10 |
33 |
17 |
18 |
|
Reaction Mixture Control |
--- |
--- |
47 |
31 |
12 |
34 |
20 |
22 |
|
Positive Controlb |
Mouse |
Liver |
>500 |
>500 |
83 |
75 |
>200 |
>200 |
|
Positive Control |
Lung |
59 |
59 |
10 |
7 |
20 |
10 |
||
Positive Control |
Testes |
42 |
60 |
11 |
10 |
11 |
10 |
||
Positive Control |
Rat |
Liver |
>300 |
>300 |
83 |
86 |
>102 |
>102 |
|
Positive Control |
Lung |
63 |
77 |
10 |
7 |
19 |
9 |
||
Positive Control |
Testes |
44 |
61 |
10 |
8 |
12 |
9 |
||
Positive Control |
Monkey |
Liver |
>100 |
>100 |
41 |
34 |
>100 |
93 |
|
Positive Control |
Lung |
71 |
54 |
9 |
8 |
20 |
6 |
||
Positive Control |
Testes |
47 |
61 |
10 |
9 |
13 |
10 |
||
Test Compound |
Mouse |
Liver |
16 |
23 |
7 |
3 |
2 |
2 |
|
Test Compound |
Lung |
35 |
15 |
0 |
4 |
1 |
2 |
||
Test Compound |
Testes |
35 |
25 |
2 |
0 |
2 |
3 |
||
Test Compound |
Rat |
Liver |
20 |
19 |
4 |
3 |
2 |
2 |
|
Test Compound |
Lung |
33 |
17 |
0 |
3 |
2 |
2 |
||
Test Compound |
Testes |
32 |
26 |
2 |
1 |
3 |
3 |
||
Test Compound |
Monkey |
Liver |
16 |
31 |
4 |
1 |
3 |
2 |
|
Test Compound |
Lung |
35 |
23 |
0 |
6 |
1 |
3 |
||
Test Compound |
Testes |
29 |
26 |
2 |
1 |
2 |
4 |
||
a |
TA-1535 |
EMS |
10 |
µL/plate |
b |
TA-1535 |
DMNA |
50 |
µm/plate |
TA-1537 |
QM |
20 |
µg/plate |
TA-1537 |
AAF |
100 |
µg/plate |
||
TA-1538 |
NF |
100 |
µg/plate |
TA-1538 |
AAF |
100 |
µg/plate |
Table 3 – Summary of Results of Non-activation experiments |
||||||
Litton Bionetics Mutagenic Activity System |
||||||
Report EXR34 |
||||||
Compound Frequency Summary Report 04/25/75 |
||||||
Compound 000299296 |
||||||
Non –activation experiments |
||||||
TA1535 |
TA1537 |
TA1538 |
0000D4 |
0000D4 |
||
HIS |
HIS |
HIS |
ADE |
TRY |
||
TEST |
DRG |
EX-8 |
EX-8 |
EX-8 |
EX-5 |
EX-5 |
NAN |
1.60 |
5.71 |
4.89 |
2.89 |
46.67 |
|
NAP |
1158.63 |
73.09 |
200.22 |
24.55 |
77.84 |
|
NA1 |
1.66 |
2.03 |
3.75 |
6.51 |
42.52 |
|
NA2 |
|
3.41 |
4.87 |
5.69 |
4. 74 |
36.50 |
Table 4 – Summary of Results of Activation experiments |
|||||||
Litton Bionetics Mutagenic Activity System |
|||||||
Report EXR34 |
|||||||
Compound Frequency Summary Report 04/25/75 |
|||||||
Species ICRFLO (Flow ICR Random Bred Mice) |
|||||||
Compound 000299296 |
|||||||
TA1535 |
TA1537 |
TA1538 |
0000D4 |
0000D4 |
|||
HIS |
HIS |
HIS |
ADE |
TRY |
|||
TEST |
DRG |
EX-8 |
EX-8 |
EX-8 |
EX-5 |
EX-5 |
|
ACT |
A + C |
5.02 |
7.20 |
3.61 |
3. 84 |
19.18 |
|
ACT |
A + T |
16.14 |
2.38 |
4.54 |
6.72 |
49.80 |
|
ACT |
A - C |
3.28 |
7.02 |
8.13 |
2.60 |
32.95 |
|
ACT |
PLI |
538.06 |
17.26 |
25.91 ' |
6.95 |
106.58 |
|
ACT |
PLU |
5.71 |
8.54 |
4.83 |
6.50 |
72.42 |
|
ACT |
PTE |
14.00 |
4.13 |
3.04 |
5.84 |
81.70 |
|
ACT |
LI1 |
1.93 |
8.16 |
5.77 |
7.82 |
50.95 |
|
ACT |
LI2 |
3.30 |
4.88 |
1.69 |
8.58 |
62.88 |
|
ACT |
LU1 |
3.11 |
9.29 |
2.86 |
6.36 |
23.93 |
|
ACT |
LU2 |
3.46 |
8.11 |
4.58 |
8.53 |
42.23 |
|
ACT |
TE1 |
3.49 |
2.13 |
2.13 |
6.56 |
26.00 |
|
ACT |
TE2 |
3.09 |
8.44 |
5.01 |
5.94 |
37.03 |
|
Species SPRDAW (Sprague Dawley Rats) |
|||||||
Compound 000299296 |
|||||||
TA1535 |
TA1537 |
TA1537 |
TA1538 |
0000D4 |
0000D4 |
||
HIS |
HIS |
HIS |
HIS |
ADE |
TRY |
||
TEST |
DRG |
EX-8 |
EX-8 |
EX-8 |
EX-8 |
EX-5 |
EX-5 |
ACT |
A + C |
1.61 |
5.41 |
1.64 |
3.41 |
3.32 |
|
ACT |
A + T |
2.25 |
1.70 |
1.11 |
1.01 |
||
ACT |
A - C |
1.49 |
3,04 |
1 .97 |
1.65 |
2.45 |
3.15 |
ACT |
PLI |
19.21 |
11.93 |
13.62 |
6.67 |
10.95 |
|
ACT |
PLU |
2.07 |
1.90 |
1,49 |
1.75 |
3.06 |
|
ACT |
PTE |
3.56 |
2.84 |
1.74 |
2.17 |
2.96 |
|
ACT |
LI1 |
1.94 |
3.86 |
2.83 |
2.69 |
2.98 |
|
ACT |
LI2 |
3.07 |
161.11 |
2.03 |
3.68 |
3.03 |
3.55 |
ACT |
LU1 |
2.42 |
242.11 |
2.07 |
2.54 |
1.67 |
3.13 |
ACT |
LU2 |
1.02 |
62.50 |
3.00 |
2.63 |
2.55 |
1.67 |
ACT |
TE1 |
7.58 |
35.94 |
2.78 |
2.26 |
4.18 |
1.83 |
ACT |
TE2 |
4.66 |
2.25 |
2.84 |
5.08 |
4.95 |
|
Species RHESUS (Rhesus Monkey (Macaca mulatta)) |
|||||||
Compound 000299296 |
|||||||
TA1535 |
TA1537 |
TA1538 |
TA1538 |
0000D4 |
0000D4 |
||
HIS |
HIS |
HIS |
HIS |
ADE |
TRY |
||
TEST |
DRG |
EX-8 |
EX-8 |
EX-8 |
EX-8 |
EX-5 |
EX-5 |
ACT |
A + C |
18.56 |
2.33 |
5.85 |
2.22 |
3.02 |
|
ACT |
A + T |
18.18 |
2.76 |
8.85 |
3.08 |
2.73 |
|
ACT |
A - C |
13.67 |
2.66 |
4.20 |
5.62 |
3.02 |
1.99 |
ACT |
PLI |
283.75 |
9.04 |
86.14 |
5.98 |
5.82 |
|
ACT |
PLU |
12.85 |
2.33 |
4.58 |
2.41 |
2.81 |
|
ACT |
PTE |
15.37 |
1.56 |
5.62 |
2.99 |
3.95 |
|
ACT |
LI1 |
19.13 |
2.51 |
152.94 |
43.75 |
3.17 |
4.95 |
ACT |
LI2 |
26.36 |
3.76 |
47.87 |
66.04 |
3.04 |
4.80 |
ACT |
LU1 |
11.28 |
2.43 |
16.10 |
5.09 |
4.95 |
|
ACT |
LU2 |
18.35 |
2.06 |
10.06 |
3.15 |
3.72 |
|
ACT |
TE1 |
19.62 |
2.58 |
17.37 |
4.39 |
4.14 |
|
ACT |
TE2 |
14.04 |
2.75 |
9.56 |
2.86 |
2.56 |
Data Table Terms and Abrreviations
COMPOUND = Client designated compound number appears in this column.
TEST CODES
NAN = Non Activation: Solvent Control
NAP = Non Activation: Positive Control
NAT = Non Activation: Test Compound Dose 1
NA2, etc. = Reflects the other dose level(s)
A+C = Negative Chemical Control
A-C = Activation: Solvent Control
ACP = Activation: Positive Control
ACT = Activation: Test Compound
A+T = Activation: Tissue Control
LI = Liver Tissue Activation Fraction
LU = Lung Tissue Activation Fraction
KI = Kidney Tissue Activation Fraction
TE = Testes Tissue Activation Fraction
1,2, etc. = Dose Levels
CONCENTRATION = All test compound dose levels are expressed as a whole number followed by an exponent (negative) identified by the appropriate units. Example: 0025-2PCT = 0.25 percent concentration
POPU = Total number of viable cells in the plating sample raised to some exponent printed directly below the abbreviation (i.e., EP + 6 = X 106).
MUT 1 = Total number of mutants or convertants obtained from the sample plated raised to some exponent printed directly below the abbreviation (i.e., EP + 0 = X 10°). For strain D4, MUT 1 represents the number of ADE+ convertants.
MUT 2 = Only used for strain D4 and represents the number of TRY+ convertants in the plated sample.
FREQ 1 = The calculated mutation or gene conversion frequency times the negative exponent written directly below. For strain D4, FREQ 1 represents the ADE+ value.
FREQ 2 = Only used for strain D4 and represents the TRY+ conversion frequency.
CONTAM = Presence of contamination on any plates.
AAF = 2-Acetylaminofluorene
DMSO = Dimethylsulfoxide
DMN = Dimethylnitrosamine
EMS = Ethyl Methanesulfonate
QM = Quinacrine Mustard
NF = Nitrofluorene
SPECIES = Animal Strains
SPRDAW = Sprague Dawley Rats
ICRFLO = Flow ICR Random Bred Mice
RHESUS = Rhesus Monkey (Macaca mulatta)
MIXEDB = Dog, Mixed Breed
NEWZEA = New Zealand White Rabbit
Cytotoxic concentration (50% survival) (μg/ml):
Sodium gluconate: 0.024 (bacteria), 50 (yeast);
Glucono-delta-lactone: 10 (bacteria), 50 (yeast);
Caclium gluconate: 50 (bacteria), 30 (yeast).
Table 1. Results of Mutation Test with iron (II) gluconate
Dose (mg/plate) |
No of Revertants /plate |
|||
|
TA97 |
TA102 |
||
|
-S9 |
+S9 |
-S9 |
+S9 |
1 |
192 |
248 |
244 |
372 |
0.5 |
187 |
251 |
222 |
425 |
0.1 |
182 |
218 |
263 |
375 |
0.05 |
205 |
217 |
235 |
372 |
0.01 |
206 |
228 |
229 |
353 |
0 |
190 |
242 |
226 |
379 |
Positive control |
1000 ± 205 |
3545 ± 396 |
3142 ± 309 |
1090 ± 195 |
Solvent: DW (not specified) |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Genetic toxicity in vivo:
To address the endpoint genetic toxicity read-across on gluconates and derivatives and iron compounds was performed within the frame of a weight-of-evidence approach.The underlying hypothesis for the read-across is that glucoheptonates and gluconates, structurally similar sugar-like carbohydrate metal-complexes, share the same metabolism pathways in mammals (they are oxidized by pentose phosphate pathway) and that their possible toxicity is a function of the metal cation rather than of the gluconate or glucoheptonate anion.
The conclusion on mutagenicity of iron glucoheptonate is based on several studies available for gluconates, its derivatives, and different iron compounds. Overall, the registered substance iron glucoheptonate is not considered to be genotoxic. In vivo studies conducted with glucono-delta-lactone and sodium gluconate did not induce chromosomal aberrations in mice, showing that no genetic toxicity can be attributed to the glucoheptonate moiety. An in vivo study with iron sulfate (Comet and micronucleus assay) had positive results. However, the dose of the test substance was that high that the genotoxic effects can be attributed to oxidative stress due to overload conditions. They are not indicative for a primary mutagenic effect. Moreover, such high intracellular Fe concentrations cannot be reached with the registered substance, iron glucoheptonate complex, in comparable in vivo settings. Another in vivo micronucleus with sodium ferric gluconate had a negative outcome. Based on these data, iron glucoheptonate is considered to be not mutagenic.
Data on sodium ferric gluconate complex in sucrose injection
Clastogenicity was evaluated in an rat micronucleus test (Sanofi-Aventis, 2009). The employed doses were 26, 52.1; and 104 mg Fe/kg. The number of micronucleated polychromatic erythrocytes was counted.
No significant increases in micronucleated polychromatic erythrocytes over the levels observed in the vehicle controls in either sex or at any of the harvest times, except in the 104 mg/kg males at the 72-hour harvest time. This is a statistical anomaly, since this was not significant compared with the female vehicle control animals and not very different from the female 104 mg/kg group at the 24-hour harvest time.
In conclusion, sodium ferric gluconate complex in sucrose injection has been shown to be negative for clastogenicity in the rat micronucleus test (sanofi-aventis, 2009).
These results are of high relevance for the substance iron glucoheptonate, since sodium ferric gluconate complex in sucrose injection is a highly recommended read across substance, due to its similar chemical behaviour and its similar uses.
Data on iron sulfate
Mice were gavaged for six consecutive days with either water or 33.2 mg/kg body weight iron. On the 7th day, the bone marrow micronucleus test and the comet assay were conducted. The results show significant genotoxicity for iron at the high doses tested. Iron induced damage to the chromosomes or the mitotic apparatus of erythroblasts and double strand breaks of DNA (Pra et al. 2008). However, it has to be considered that the test dose was very high (33.2 mg/kg body weight/day). The recommended daily iron intake for adult human is between 10 and 15 mg/day (Deutsche Gesellschaft für Ernährung). This corresponds to about 0.2 mg/kg body weight/day. It can be assumed that the need in iron is not significantly higher for mice than for human. Therefore, the mice in this study were exposed to an enormous iron overload. This might have induced cellular stress leading to the formation of reactive oxygen species, which can cause DNA damage. Considering the fact that iron glucoheptonate has an iron content of only 12 %, an even higher dose of iron glucoheptonate would be required to induce the same effect.
Data on gluconates and derivatives
Sodium gluconate and glucono-delta-lactone were tested for induction of chromosomal aberrations in mouse bone marrow cells after an oral single and a 4 days repeated dose administration. At least 200 metaphase cells per mouse were scored (C57BL male mice) and were examined for the presence or absence of chromosomal aberrations (gaps, breaks, translocation, fragments, ring chromosomes and minutes chromosomes). The frequency of cells with chromosomal aberrations in the test groups was comparable to the control group in both experiments: single administration and 4-d repeat administration. In conclusion, the test item is considered to be negative for genetic mutagenicity (SIDS 2004, CIR 2014).
Moreover, single dose administration tests of sodium gluconate at doses of 2.5, 5 and 10 g/kg were performed.
Induction of chromosomal aberration by sodium gluconate was not detected after in vivo single and repeated dose treatment. Thus, sodium gluconate is considered negative for mutagenicity.
Link to relevant study records
- Endpoint:
- in vivo mammalian germ cell study: cytogenicity / chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate on releasing their metals that can further interact with a variety of cellular proteins, while no genetic toxicity potential can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, leading to adverse mutagenicity and/or clastogenicity effects. So, information on genetic toxicity of gluconate anion allows to strengthen the read-across approach, excluding genetic toxicity potential of the organic part of the molecule.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Based on the negative results from in vitro studies and the negative results in the micronucleus test in vivo with ammonium chloride a mutagenic activity of ammonium sulfate in vivo is unlikely (OECD SIDS, 2004). Therefore, the iron ion is the only toxicological relevant component of the registered substance.
Gluconates used in genetic toxicity studies described in this record do not include impurities that are different from those contained in the target substance and which would influence genetic toxicity potential. Moreover, since the data originate from a review, no detailed information on purity and impurities could be extracted. However, the results on mutagenicity of gluconates summarised in this Cosmetic ingredient review are peer-reviewed and therefore any impurity that would influence mutagenicity result of the tested substances is assessed by the Panel and therefore could be excluded as not relevant for the present assessment.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconates are not mutagenic in bacterial strains. Due to high structural similarity and the fact that gluconates and glucoheptonates are carbohydrates used by cells in high amounts, no mutagenicity is expected for glucoheptonate anion.
4. DATA MATRIX
data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- in both experiments: single administration and 4-d repeated dose administration.
- Toxicity:
- yes
- Remarks:
- At 8 g/kg, all mice died (single dose administration experiment)
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- The frequency of cells with chromosomal aberrations in the test groups was comparable to the control group in both experiments: single administartion and 4-d repeat administration. The test item is considered to be negative for genetic mutagenicity.
These results are also relevant for iron glucoheptonate, as the glucoheptonate-residue is also a derivative of gluconic acid. Therefore, the fact that these gluconates are not mutagenic is important. - Executive summary:
Sodium gluconate and glucono-delta-lactone were tested for induction of chromosomal aberrations in mouse bone marrow cells after an oral single and a 4 days repeated dose administration. At least 200 metaphase cells per mouse were scored (C57BL male mice) and were examined for the presence or absence of chromosomal aberrations (gaps, breaks, translocation, fragments, ring chromosomes and minutes chromosomes).
After single dose administration of glucono-delta-lactone: at 2 and 4 g/kg the number of chromosomal aberration was unchanged compared to control (both at a frequency of about 0.5 %). At 8 g/kg all mice died and the presence or absence of chromosomal aberration could not be determined. The positive control Mitomycin C induced chromosomal aberration in at least 20 % of bone marrow cells.
GDL induced chromosomal aberrations in the cells at a frequency of about 0.5% comparable to the control.
After a 4-day repeated dose administration of glucono-delta-lactone the positive control mitomycin C induced chromosomal aberrations at about 30% cells. However, the frequency of cells with chromosomal aberrations in the test groups (2 g/kg and 4 g/kg) was comparable to the control group.
In conclusion, the frequency of cells with chromosomal aberrations in the test groups was comparable to the control group in both experiments: single administration and 4-d repeat administration. The test item is considered to be negative for genetic mutagenicity.
These results are also relevant for iron glucoheptonate, as the glucoheptonate-residue is also a derivative of gluconic acid. Therefore, the fact that these gluconates are not mutagenic is important.
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate in organic fluids releasing their metals that can further interact with a variety of biomolecules, while no genetic toxicity can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, producing an adverse genotoxicity effects. Therefore, data on genetic toxicity potential of several organic and inorganic iron compounds have been taken into account to address genetic toxicity potential of iron cation which could be released from the iron glucoheptonate.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Source Chemical: sodium ferric gluconate complex in sucrose injection
Each vial of 5 mL of FERRLECIT contains 12.5 mg/mL (62.5 mg/5 mL vial) of elemental iron as the sodium salt of a ferric ion gluconate complex in alkaline aqueous solution with approximately 20% sucrose w/v (195 mg/mL) in Water for Injection (pH 7.7 - 9.7). The solution contains 0.9% w/v (9 mg/mL) benzyl alcohol as preservative.
It is used to replete and maintain the total body content of iron.
The substances do not contain impurities to an extent which is expected to alter the outcome of the experimental results or read-across approach.
Target Chemical: Sodium Iron glucoheptonate complex (HGA:Fe-1:1), CAS 1821694-04-5,
SMILES [Na+].[H]C([H])(O)C([H])(O)C1([H])O[Fe]2OC([H])(C([O-])=O)C([H])(O2)C1([H])O,
MW 354.8 g/mol (trihydrated from) or 300.8g/mol (anhydrous form)
The molecular formula is C7FeH10NaO8 *3H2O (trihydrated form).
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The calculation of a hazard value for iron glucoheptonate is based on 76 % content of iron glucoheptonate in the registered product. Another component is Na2SO4. Sodium is a macroelement occurring in surface waters and in living organisms in considerable amounts. Sulfur species are also found in living organisms. Thus, these cations and anions are considered not to impact the toxicity of iron glucoheptonate.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconate and glucoheptonate anions share similar chemical moiety. Iron is also the same cation in both chemicals. They dissociate according the same scheme: 1:1 iron and gluconate or glucoheptonate are released. Therefore, genetic toxicity of both chemicals is expected to be very similar.
4. DATA MATRIX
data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Sex:
- male/female
- Genotoxicity:
- negative
- Conclusions:
- The results indicate that Ferrlecit is not mutagenic in the rat micronucleus test.
These results are of high relevance for the substance iron glucoheptonate, since sodium ferric gluconate complex in sucrose injection is a highly recommended read across substance, due to its similar chemical behaviour and its similar uses. - Executive summary:
Clastogenicity was evaluated in an rat micronucleus test. The employed doses were 26, 52.1; and 104 mg Fe/kg. The number of micronucleated polychromatic erythrocytes was counted.
No significant increases in micronucleated polychromatic erythrocytes over the levels observed in the vehicle controls in either sex or at any of the harvest times, except in the 104 mg/kg males at the 72-hour harvest time. This is a statistical anomaly, since this was not significant compared with the female vehicle control animals and not very different from the female 104 mg/kg group at the 24-hour harvest time. Due to toxicity, the PCE/NCE (poly- to normochromatic erythrocyte) ratio of the 26.0, 52.1, and 104 mg/kg dose groups at the 48 -hour harvest time, and the positive control males and females were significantly lower than the vehicle control group. The positive control, cyclophosphamide, induced significant increases in micronucleated PCEs in both sexes as compared to the vehicle control, with means and standard errors of 3.44%"0.66% and 2.02%"0.36% for the males and females, respectively.
The results indicate that Ferrlecit is not mutagenic in the rat micronucleus test.
These results are of high relevance for the substance iron glucoheptonate, since sodium ferric gluconate complex in sucrose injection is a highly recommended read across substance, due to its similar chemical behaviour and its similar uses.
- Endpoint:
- in vivo mammalian germ cell study: cytogenicity / chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate on releasing their metals that can further interact with a variety of cellular proteins, while no genetic toxicity potential can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, leading to adverse mutagenicity and/or clastogenicity effects. So, information on genetic toxicity of gluconate anion allows to strengthen the read-across approach, excluding genetic toxicity potential of the organic part of the molecule.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Based on the negative results from in vitro studies and the negative results in the micronucleus test in vivo with ammonium chloride a mutagenic activity of ammonium sulfate in vivo is unlikely (OECD SIDS, 2004). Therefore, the iron ion is the only toxicological relevant component of the registered substance.
Gluconates used in genetic toxicity studies described in this record do not include impurities that are different from those contained in the target substance and which would influence genetic toxicity potential. Moreover, since the data originate from a review, no detailed information on purity and impurities could be extracted. However, the results on mutagenicity of gluconates summarised in this Cosmetic ingredient review are peer-reviewed and therefore any impurity that would influence mutagenicity result of the tested substances is assessed by the Panel and therefore could be excluded as not relevant for the present assessment.
3. ANALOGUE APPROACH JUSTIFICATION
Gluconates are not mutagenic in bacterial strains. Due to high structural similarity and the fact that gluconates and glucoheptonates are carbohydrates used by cells in high amounts, no mutagenicity is expected for glucoheptonate anion.
4. DATA MATRIX
data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- in both experiments: single dose administration and 4-d repeated dose administration.
- Toxicity:
- yes
- Remarks:
- At 10 and 5 g/kg, all mice died (single dose administration); at 1.25 and 2.5 g/kg, one mouse died in each group (4-day repeated dose administration).
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Conclusions:
- Interpretation of results (migrated information): negative
Induction of chromosomal aberration by sodium gluconate was not detected after in vivo single and repeated dose treatment. The test item is considered negative for mutagenicity. - Executive summary:
Single dose administration tests of sodium gluconate at doses of 2.5, 5 and 10 g/kg were performed. At 10 and 5 g/kg, all mice died. At 2.5 g/kg, observations could be made only on 2 animals (preparation of the chromosome specimen failed). The positive control mitomycin C induced chromosomal aberrations in at least 20% of bone marrow cells. Sodium gluconate induced chromosomal aberrations in the cells at a frequency of about 0.5% is comparable to the control. (1 gap and 1 minute chromosome for 283 cells).
After 4-day repeated dose administration of sodium gluconate, one mouse of 2 or 3 animals, respectively, died in each group after doses of 1.25 and 2.5 g/kg. The positive control mitomycin C induced chromosomal aberrations at about 30% cells. The frequency of cells with chromosomal aberrations was 0.5% in the test groups which is comparable to the control group.
In conclusion, induction of chromosomal aberration by sodium gluconate was not detected after in vivo single and repeated dose treatment. The test item is considered negative for mutagenicity.
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate in organic fluids releasing their metals that can further interact with a variety of biomolecules, while no genetic toxicity can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, producing an adverse genotoxicity effect. Therefore, data on genetic toxicity potential of several organic and inorganic copper compounds have been taken into account to address genetic toxicity potential of iron cation which could be released from the iron glucoheptonate.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Based on the negative results from in vitro studies and the negative results in the micronucleus test in vivo with ammonium chloride a mutagenic activity of ammonium sulfate in vivo is unlikely (OECD SIDS, 2004). Therefore, the iron ion is the only toxicological relevant component of the registered substance.
The purity of the iron compounds used in this study range between 98 and 100 %.
3. ANALOGUE APPROACH JUSTIFICATION
Since glucoheptonate anion is considered not mutagenic to bacterial strains, certain mutagenicity potential, if any, could be attributed to iron. Therefore, data on mutagenicity of inorganic iron compounds are used to address mutagenicity of iron.
4. DATA MATRIX
please refer to the detailled data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Dose / conc.:
- 33.23 mg/kg bw/day
- Remarks:
- elemental iron
- Sex:
- male/female
- Genotoxicity:
- positive
- Toxicity:
- not examined
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- The current results show significant genotoxicity for iron at the high doses tested. Iron induces damage to the chromosomes or the mitotic apparatus of erythroblasts. Due to the fact that the chelated iron of the target substance iron glucoheptonate is released in the body, these results are of high relevance.
- Executive summary:
Mice were gavaged for six consecutive days with either water or 33.2 mg/kg body weight iron. On the 7th day, the bone marrow micronucleus test was used as genotoxicity endpoint. The results show significant genotoxicity for iron at the high doses tested. Iron induces damage to the chromosomes or the mitotic apparatus of erythroblasts.
Due to the fact that the chelated iron of the target substance iron glucoheptonate is released in the body, these results are of high relevance.
- Endpoint:
- in vivo mammalian cell study: DNA damage and/or repair
- Remarks:
- comet assay
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Please refer to read-across statement attached under section 13 of this IUCLID file.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
Genetic toxicity potential of gluconates and glucoheptonates is believed to be driven by metal cation bonded to the organic part of the molecule and not by the organic part itself. Gluconates and glucoheptonates can dissociate in organic fluids releasing their metals that can further interact with a variety of biomolecules, while no genetic toxicity can be attributed to the organic part of the molecule. This is because gluconates and glucoheptonates are structurally similar sugar-like substances with the same functional groups (sugar backbone), which are not known to bind to DNA, producing an adverse genotoxicity effect. Therefore, data on genetic toxicity potential of several organic and inorganic iron compounds have been taken into account to address genetic toxicity potential of iron cation which could be released from the iron glucoheptonate.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
Information on purity of the registered substance is provided in the target record under "Test material" as confidential. The iron glucoheptonate content in the registered product is 76 %. Other components are ammonium sulfate and sodium sulfate. Ammonium sulfate and sodium sulfate are considered not to impact the genetic toxicity of the target substance to a significant degree. Based on the negative results from in vitro studies and the negative results in the micronucleus test in vivo with ammonium chloride a mutagenic activity of ammonium sulfate in vivo is unlikely (OECD SIDS, 2004). Therefore, the iron ion is the only toxicological relevant component of the registered substance.
The purity of the iron compounds used in this study range between 98 and 100 %.
3. ANALOGUE APPROACH JUSTIFICATION
Since glucoheptonate anion is considered not mutagenic to bacterial strains, certain mutagenicity potential, if any, could be attributed to iron. Therefore, data on mutagenicity of inorganic iron compounds are used to address mutagenicity of iron.
4. DATA MATRIX
please refer to the detailled data matrix attached in section 13. - Reason / purpose for cross-reference:
- read-across source
- Dose / conc.:
- 33.23 mg/kg bw/day
- Remarks:
- elemental iron
- No. of animals per sex per dose:
- 5 males and 5 females
- Sex:
- male/female
- Genotoxicity:
- positive
- Remarks:
- iron sulfate
- Toxicity:
- not examined
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- The current results show significant genotoxicity for iron at the high doses tested. Iron seems to induce double strand breaks, single strand breaks and alkali labile sites at a considerable level. Continuous treatment with iron probably led to an accumulation of oxidative lesions in DNA that act as alkali labile sites or excision repair sites. Due to the fact that the chelated iron of the target substance iron glucoheptonate is released in the body, these results are of high relevance. It indicates that iron glucoheptonate might be genotoxic.
- Executive summary:
Mice were gavaged for six consecutive days with either water or 33.2 mg/kg body weight iron. On the 7th day, the neutral and alkaline comet assays in whole blood was used as genotoxicity endpoint. The results show significant genotoxicity for iron at the high doses tested. Iron seems to induce double strand breaks, single strand breaks and alkali labile sites at a considerable level. Continuous treatment with iron probably led to an accumulation of oxidative lesions in DNA that act as alkali labile sites or excision repair sites. Due to the fact that the chelated iron of the target substance iron glucoheptonate is released in the body, these results are of high relevance. It indicates that iron glucoheptonate might be genotoxic.
Referenceopen allclose all
Single dose administration:
At 8 g/kg, all mice died.
MMC induced chromosomal aberrations in at least 20% of bone marrow cells.
GDL induced chromosomal aberrations in the cells at a frequency of about 0.5% comparable to the control.
4-day repeated dose administration:
MMC induced chromosomal aberrations at about 30% cells.
The frequency of cells with chromosomal aberrations was 1 % or less in the test groups which is comparable to the control group. Induction of chromosomal aberration by GDL was not detected after in vivo single and repeated dose treatment.
No significant increases in micronucleated polychromatic erythrocytes over the levels observed in the vehicle controls in either sex or at any of the harvest times, except in the 104 mg/kg males at the 72-hour harvest time. This is a statistical anomaly, since this was not significant compared with the female vehicle control animals and not very different from the female 104 mg/kg group at the 24-hour harvest time. Due to toxicity, the PCE/NCE (poly- to normochromatic erythrocyte) ratio of the 26.0, 52.1, and 104 mg/kg dose groups at the 48-hour harvest time, and the positive control males and females were significantly lower than the vehicle control group. The positive control, cyclophosphamide, induced significant increases in micronucleated PCEs in both sexes as compared to the vehicle control, with means and standard errors of 3.44%"0.66% and 2.02%"0.36% for the males and females, respectively. The results indicate that Ferrlecit is not mutagenic in the rat micronucleus test.
Single dose administration:
At 10 and 5 g/kg, all mice died.
At 2.5 g/kg, observation could be made only on 2 animals (preparation of the chromosome specimen failed).
MMC induced chromosomal aberrations in at least 20% of bone marrow cells. Sodium gluconate induced chromosomal aberrations in the cells at a frequency of about 0.5% is comparable to the control. (1 gap and 1 minute chromosome for 283 cells).
4-day repeated dose administration:
At 1.25 and 2.5 g/kg, one mouse died in each group.
MMC induced chromosomal aberrations at about 30% cells. The frequency of cells with chromosomal aberrations was 0.5% in the test groups which is comparable to the control group.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for classification or non-classification
Based on all available information, the substance not classified as mutagenic and therefore does not have to be labelled as mutagenic substance according to European Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.